2026 ICD-10-CM Diagnosis Code C95.92Leukemia, unspecified, in relapse

AHRQ’s CCSR groups this code into broader clinical categories.

• Abelson murine leukemia virus

  a replication-defective strain of murine leukemia virus (leukemia virus, murine) capable of transforming lymphoid cells and producing a rapidly progressing lymphoid leukemia after superinfection with friend murine leukemia virus; moloney murine leukemia virus; or rauscher virus.

• Anemia, Refractory, with Excess of Blasts

  chronic refractory anemia with granulocytopenia, and/or thrombocytopenia. myeloblasts and progranulocytes constitute 5 to 40 percent of the nucleated marrow cells.

• Burkitt Lymphoma

  a form of undifferentiated malignant lymphoma usually found in central africa, but also reported in other parts of the world. it is commonly manifested as a large osteolytic lesion in the jaw or as an abdominal mass. b-cell antigens are expressed on the immature cells that make up the tumor in virtually all cases of burkitt lymphoma. the epstein-barr virus (herpesvirus 4, human) has been isolated from burkitt lymphoma cases in africa and it is implicated as the causative agent in these cases; however, most non-african cases are ebv-negative.

• Deltaretrovirus

  a genus in the family retroviridae consisting of exogenous horizontally-transmitted viruses found in a few groups of mammals. infections caused by these viruses include human b- or adult t-cell leukemia/lymphoma (leukemia-lymphoma, t-cell, acute, htlv-i-associated), and bovine leukemia (enzootic bovine leukosis). the type species is leukemia virus, bovine.

• Deltaretrovirus Antibodies

  antibodies reactive with various types of human t-cell leukemia/lymphoma antigens or bovine leukemia virus antigens.

• Deltaretrovirus Antigens

  antigens associated with the deltaretrovirus; htlv-i antigens and htlv-ii antigens belong to this group.

• Enzootic Bovine Leukosis

  a lymphoid neoplastic disease in cattle caused by the bovine leukemia virus. enzootic bovine leukosis may take the form of lymphosarcoma, malignant lymphoma, or leukemia but the presence of malignant cells in the blood is not a consistent finding.

• HTLV-I Antibodies

  antibodies reactive with the htlv-i antigens.

• HTLV-I Antigens

  antigens associated with human t-lymphotropic virus 1.

• HTLV-II Antibodies

  antibodies reactive with the htlv-ii antigens.

• HTLV-II Antigens

  antigens associated with human t-lymphotropic virus 2.

• Human T-lymphotropic virus 1

  a strain of primate t-lymphotropic virus 1 isolated from mature t4 cells in patients with t-lymphoproliferation malignancies. it causes adult t-cell leukemia (leukemia-lymphoma, t-cell, acute, htlv-i-associated), t-cell lymphoma (lymphoma, t-cell), and is involved in mycosis fungoides, sezary syndrome and tropical spastic paraparesis (paraparesis, tropical spastic).

• Human T-lymphotropic virus 2

  a strain of primate t-lymphotropic virus 2 that can transform normal t-lymphocytes and can replicate in both t- and b-cell lines. the virus is related to but distinct from htlv-1.

• Hypereosinophilic Syndrome

  a heterogeneous group of disorders with the common feature of prolonged eosinophilia of unknown cause and associated organ system dysfunction, including the heart, central nervous system, kidneys, lungs, gastrointestinal tract, and skin. there is a massive increase in the number of eosinophils in the blood, mimicking leukemia, and extensive eosinophilic infiltration of the various organs.

• Leukemia

  a progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (from the merck manual, 2006)

• Leukemia Inhibitory Factor

  an interleukin-6 related cytokine that exhibits pleiotrophic effects on many physiological systems that involve cell proliferation, differentiation, and survival. leukemia inhibitory factor binds to and acts through the lif receptor.

• Leukemia Inhibitory Factor Receptor alpha Subunit

  a receptor subunit that combines with cytokine receptor gp130 to form the dual specificity receptor for leukemia inhibitory factor and oncostatin m. the subunit is also a component of the ciliary neurotrophic factor receptor. both membrane-bound and secreted isoforms of the receptor subunit exist due to alternative splicing of its mrna. the secreted isoform is believed to act as an inhibitory receptor, while the membrane-bound form is a signaling receptor.

• Leukemia L1210

  an experimental lymphocytic leukemia of mice.

• Leukemia L5178

  an experimental lymphocytic leukemia of mice.

• Leukemia P388

  an experimental lymphocytic leukemia originally induced in dba/2 mice by painting with methylcholanthrene.

• Leukemia Virus, Bovine

  the type species of deltaretrovirus that causes a form of bovine lymphosarcoma (enzootic bovine leukosis) or persistent lymphocytosis.

• Leukemia Virus, Feline

  a species of gammaretrovirus causing leukemia, lymphosarcoma, immune deficiency, or other degenerative diseases in cats. several cellular oncogenes confer on felv the ability to induce sarcomas (see also sarcoma viruses, feline).

• Leukemia Virus, Gibbon Ape

  a species of gammaretrovirus causing leukemia in the gibbon ape. natural transmission is by contact.

• Leukemia Virus, Murine

  species of gammaretrovirus, containing many well-defined strains, producing leukemia in mice. disease is commonly induced by injecting filtrates of propagable tumors into newborn mice.

• Leukemia, Basophilic, Acute

  a rare acute myeloid leukemia in which the primary differentiation is to basophils. it is characterized by an extreme increase of immature basophilic granulated cells in the bone marrow and blood. mature basophils are usually sparse.

• Leukemia, B-Cell

  a malignant disease of the b-lymphocytes in the bone marrow and/or blood.

• Leukemia, Biphenotypic, Acute

  an acute leukemia exhibiting cell features characteristic of both the myeloid and lymphoid lineages and probably arising from multipotent stem cells.

• Leukemia, Eosinophilic, Acute

  a rare acute myeloid leukemia characterized by abnormal eosinophils in the bone marrow.

• Leukemia, Erythroblastic, Acute

  a myeloproliferative disorder characterized by neoplastic proliferation of erythroblastic and myeloblastic elements with atypical erythroblasts and myeloblasts in the peripheral blood.

• Leukemia, Experimental

  leukemia induced experimentally in animals by exposure to leukemogenic agents, such as viruses; radiation; or by transplantation of leukemic tissues.

• Leukemia, Feline

  a neoplastic disease of cats frequently associated with feline leukemia virus infection.

• Leukemia, Hairy Cell

  a neoplastic disease of the lymphoreticular cells which is considered to be a rare type of chronic leukemia; it is characterized by an insidious onset, splenomegaly, anemia, granulocytopenia, thrombocytopenia, little or no lymphadenopathy, and the presence of hairy or flagellated cells in the blood and bone marrow.

• Leukemia, Large Granular Lymphocytic

  a spectrum of disorders characterized by clonal expansions of the peripheral blood lymphocyte populations known as large granular lymphocytes which contain abundant cytoplasm and azurophilic granules. subtypes develop from either cd3-negative natural killer cells or cd3-positive t-cells. the clinical course of both subtypes can vary from spontaneous regression to progressive, malignant disease.

• Leukemia, Lymphocytic, Chronic, B-Cell

  a chronic leukemia characterized by abnormal b-lymphocytes and often generalized lymphadenopathy. in patients presenting predominately with blood and bone marrow involvement it is called chronic lymphocytic leukemia (cll); in those predominately with enlarged lymph nodes it is called small lymphocytic lymphoma. these terms represent spectrums of the same disease.

• Leukemia, Lymphoid

  leukemia associated with hyperplasia of the lymphoid tissues and increased numbers of circulating malignant lymphocytes and lymphoblasts.

• Leukemia, Mast-Cell

  a form of systemic mastocytosis (mastocytosis, systemic) characterized by the presence of large numbers of tissue mast cells in the peripheral blood without skin lesions. it is a high-grade leukemia disease with bone marrow smear of >20% mast cells, multi-organ failure and a short survival.

• Leukemia, Megakaryoblastic, Acute

  an acute myeloid leukemia in which 20-30% of the bone marrow or peripheral blood cells are of megakaryocyte lineage. myelofibrosis or increased bone marrow reticulin is common.

• Leukemia, Monocytic, Acute

  an acute myeloid leukemia in which 80% or more of the leukemic cells are of monocytic lineage including monoblasts, promonocytes, and monocytes.

• Leukemia, Myelogenous, Chronic, BCR-ABL Positive

  clonal hematopoetic disorder caused by an acquired genetic defect in pluripotent stem cells. it starts in myeloid cells of the bone marrow, invades the blood and then other organs. the condition progresses from a stable, more indolent, chronic phase (leukemia, myeloid, chronic phase) lasting up to 7 years, to an advanced phase composed of an accelerated phase (leukemia, myeloid, accelerated phase) and blast crisis.

• Leukemia, Myeloid

  form of leukemia characterized by an uncontrolled proliferation of the myeloid lineage and their precursors (myeloid progenitor cells) in the bone marrow and other sites.

• Leukemia, Myeloid, Accelerated Phase

  the phase of chronic myeloid leukemia following the chronic phase (leukemia, myeloid, chronic-phase), where there are increased systemic symptoms, worsening cytopenias, and refractory leukocytosis.

• Leukemia, Myeloid, Acute

  clonal expansion of myeloid blasts in bone marrow, blood, and other tissue. myeloid leukemias develop from changes in cells that normally produce neutrophils; basophils; eosinophils; and monocytes.

• Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

  a myelodysplastic/myeloproliferative disorder characterized by myelodysplasia associated with bone marrow and peripheral blood patterns similar to chronic myeloid leukemia, but cytogenetically lacking a philadelphia chromosome or bcr/abl fusion gene (genes, abl).

• Leukemia, Myeloid, Chronic-Phase

  the initial phase of chronic myeloid leukemia consisting of an relatively indolent period lasting from 4 to 7 years. patients range from asymptomatic to those exhibiting anemia; splenomegaly; and increased cell turnover. there are 5% or fewer blast cells in the blood and bone marrow in this phase.

• Leukemia, Myelomonocytic, Acute

  a pediatric acute myeloid leukemia involving both myeloid and monocytoid precursors. at least 20% of non-erythroid cells are of monocytic origin.

• Leukemia, Myelomonocytic, Chronic

  a myelodysplastic-myeloproliferative disease characterized by monocytosis, increased monocytes in the bone marrow, variable degrees of dysplasia, but an absence of immature granulocytes in the blood.

• Leukemia, Myelomonocytic, Juvenile

  a leukemia affecting young children characterized by splenomegaly, enlarged lymph nodes, rashes, and hemorrhages. traditionally classed as a myeloproliferative disease, it is now considered a mixed myeloproliferative-mylelodysplastic disorder.

• Leukemia, Neutrophilic, Chronic

  a rare myeloproliferative disorder that is characterized by a sustained, mature neutrophilic leukocytosis. no monocytosis, eosinophilia, or basophilia is present, nor is there a philadelphia chromosome or bcr-abl fusion gene (genes, abl).

• Leukemia, Plasma Cell

  a rare, aggressive variant of multiple myeloma characterized by the circulation of excessive plasma cells in the peripheral blood. it can be a primary manifestation of multiple myeloma or develop as a terminal complication during the disease.

• Leukemia, Prolymphocytic

  a chronic leukemia characterized by a large number of circulating prolymphocytes. it can arise spontaneously or as a consequence of transformation of chronic lymphocytic leukemia.

• Leukemia, Prolymphocytic, B-Cell

  a neoplasm of prolymphocytes affecting the blood, bone marrow, and spleen. it is characterized by prolymphocytes exceeding 55% of the lymphoid cells in the blood and profound splenomegaly.

• Leukemia, Prolymphocytic, T-Cell

  a lymphoid leukemia characterized by a profound lymphocytosis with or without lymphadenopathy, hepatosplenomegaly, frequently rapid progression, and short survival. it was formerly called t-cell chronic lymphocytic leukemia.

• Leukemia, Promyelocytic, Acute

  an acute myeloid leukemia in which abnormal promyelocytes predominate. it is frequently associated with disseminated intravascular coagulation.

• Leukemia, Radiation-Induced

  leukemia produced by exposure to ionizing radiation or non-ionizing radiation.

• Leukemia, T-Cell

  a malignant disease of the t-lymphocytes in the bone marrow, thymus, and/or blood.

• Leukemia-Lymphoma, Adult T-Cell

  aggressive t-cell malignancy with adult onset, caused by human t-lymphotropic virus 1. it is endemic in japan, the caribbean basin, southeastern united states, hawaii, and parts of central and south america and sub-saharan africa.

• Moloney murine leukemia virus

  a strain of murine leukemia virus (leukemia virus, murine) arising during the propagation of s37 mouse sarcoma, and causing lymphoid leukemia in mice. it also infects rats and newborn hamsters. it is apparently transmitted to embryos in utero and to newborns through mother's milk.

• Precursor B-Cell Lymphoblastic Leukemia-Lymphoma

  a leukemia/lymphoma found predominately in children and adolescents and characterized by a high number of lymphoblasts and solid tumor lesions. frequent sites involve lymph nodes, skin, and bones. it most commonly presents as leukemia.

• Precursor Cell Lymphoblastic Leukemia-Lymphoma

  a neoplasm characterized by abnormalities of the lymphoid cell precursors leading to excessive lymphoblasts in the marrow and other organs. it is the most common cancer in children and accounts for the vast majority of all childhood leukemias.

• Precursor T-Cell Lymphoblastic Leukemia-Lymphoma

  a leukemia/lymphoma found predominately in children and young adults and characterized lymphadenopathy and thymus gland involvement. it most frequently presents as a lymphoma, but a leukemic progression in the bone marrow is common.

• Radiation Leukemia Virus

  a strain of murine leukemia virus (leukemia virus, murine) isolated from radiation-induced lymphomas in c57bl mice. it is leukemogenic, thymotrophic, can be transmitted vertically, and replicates only in vivo.

• Rauscher Virus

  a strain of murine leukemia virus associated with mouse tumors similar to those caused by the friend murine leukemia virus. it is a replication-competent murine leukemia virus. it can act as a helper virus when complexing with a defective transforming component, rauscher spleen focus-forming virus.

• Receptors, OSM-LIF

  cell surface receptors formed from the dimerization of lif receptor alpha subunit with cytokine receptor gp130. although originally described as receptors for leukemia inhibitory factor these receptors also bind the closely-related protein oncostatin m and are referred to as both lif receptors and type i oncostatin m receptors.

• Stathmin

  a ubiquitous phosphoprotein that serves as an intracellular substrate for a variety of signal transduction pathways. phosphorylation of stathmin occurs during cell cycle progression, and stathmin functions as a microtubule-destabilizing protein that promotes microtubule depolymerization during interphase and late mitosis. stathmin is expressed at very high levels in a variety of human cancers.

• Tetraspanin 29

  a subtype of tetraspanin protein that plays a role in cell adhesion, cell motility, and tumor metastasis. it functions in platelet activation and aggregation, the formation of paranodal junctions in neuronal tissue, and the fusion of sperm with egg.

• Eosinophils

  granular leukocytes with a nucleus that usually has two lobes connected by a slender thread of chromatin, and cytoplasm containing coarse, round granules that are uniform in size and stainable by eosin.

• Interleukin-6

  a cytokine that stimulates the growth and differentiation of b-lymphocytes and is also a growth factor for hybridomas and plasmacytomas. it is produced by many different cells including t-lymphocytes; monocytes; and fibroblasts.

• Gammaretrovirus

  a genus of retroviridae comprising endogenous sequences in mammals, related reticuloendotheliosis viruses, avian, and a reptilian virus. many species contain oncogenes and cause leukemias and sarcomas.

• Basophils

  granular leukocytes characterized by a relatively pale-staining, lobate nucleus and cytoplasm containing coarse dark-staining granules of variable size and stainable by basic dyes.

• B-Lymphocytes

  lymphoid cells concerned with humoral immunity. they are short-lived cells resembling bursa-derived lymphocytes of birds in their production of immunoglobulin upon appropriate stimulation.

• Multipotent Stem Cells

  specialized stem cells that are committed to give rise to cells that have a particular function; examples are myoblasts; myeloid progenitor cells; and skin stem cells. (stem cells: a primer [internet]. bethesda (md): national institutes of health (us); 2000 may [cited 2002 apr 5]. available from: http://www.nih.gov/news/stemcell/primer.htm)

• Monocytes

  large, phagocytic mononuclear leukocytes produced in the vertebrate bone marrow and released into the blood; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles.

• Myeloid Progenitor Cells

  stem cells derived from hematopoietic stem cells. derived from these myeloid progenitor cells are the megakaryocytes; erythroid cells; myeloid cells; and some dendritic cells.

• Splenomegaly

  enlargement of the spleen.

• T-Lymphocytes

  lymphocytes responsible for cell-mediated immunity. two types have been identified - cytotoxic (t-lymphocytes, cytotoxic) and helper t-lymphocytes (t-lymphocytes, helper-inducer). they are formed when lymphocytes circulate through the thymus gland and differentiate to thymocytes. when exposed to an antigen, they divide rapidly and produce large numbers of new t cells sensitized to that antigen.

• Lymph Nodes

  they are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system.

Leukemia

Leukemia is a term for cancers of the blood cells. Leukemia starts in blood-forming tissues such as the bone marrow. Your bone marrow makes the cells which will develop into white blood cells, red blood cells, and platelets. Each type of cell has a different job:

The full article covers:

• What is leukemia?
• What are the types of leukemia?
• What causes leukemia?
• Who is at risk for leukemia?
• What are the symptoms of leukemia?
• How is leukemia diagnosed?
• What are the treatments for leukemia?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.